AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109. A total of 71 filers reported holding AVEO PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $21,000 | -80.9% | 32,308 | -76.3% | 0.00% | – |
Q1 2019 | $110,000 | -51.8% | 136,225 | -5.2% | 0.00% | – |
Q4 2018 | $228,000 | -84.4% | 143,623 | -67.6% | 0.00% | – |
Q3 2018 | $1,465,000 | +82.2% | 443,169 | +24.5% | 0.00% | – |
Q2 2018 | $804,000 | +1118.2% | 355,987 | +1086.6% | 0.00% | – |
Q2 2017 | $66,000 | – | 30,000 | +68081.8% | 0.00% | – |
Q2 2016 | $0 | -100.0% | 44 | -98.5% | 0.00% | – |
Q4 2015 | $3,000 | 0.0% | 2,904 | +16.2% | 0.00% | – |
Q3 2015 | $3,000 | -85.7% | 2,500 | -80.0% | 0.00% | – |
Q2 2015 | $21,000 | -83.3% | 12,500 | -85.8% | 0.00% | – |
Q1 2015 | $126,000 | +6200.0% | 87,767 | +3410.7% | 0.00% | – |
Q4 2014 | $2,000 | -91.7% | 2,500 | -88.8% | 0.00% | – |
Q3 2014 | $24,000 | -89.9% | 22,306 | -83.0% | 0.00% | – |
Q2 2014 | $237,000 | -63.3% | 131,005 | -69.7% | 0.00% | – |
Q1 2014 | $646,000 | -35.8% | 432,864 | -21.4% | 0.00% | -100.0% |
Q4 2013 | $1,007,000 | -47.1% | 550,694 | -40.4% | 0.00% | 0.0% |
Q3 2013 | $1,902,000 | – | 923,850 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 20,896,038 | $17,135,000 | 0.89% |
X-Square Capital, LLC | 270,680 | $222,000 | 0.15% |
New Leaf Venture Partners, L.L.C. | 402,118 | $330,000 | 0.09% |
GSA CAPITAL PARTNERS LLP | 688,431 | $565,000 | 0.06% |
EXCALIBUR MANAGEMENT CORP | 51,000 | $42,000 | 0.04% |
WealthTrust Axiom LLC | 138,505 | $113,000 | 0.04% |
Caption Management, LLC | 855,200 | $701,000 | 0.04% |
Evercore Wealth Management, LLC | 418,414 | $343,000 | 0.01% |
Gemmer Asset Management LLC | 1,939 | $32,000 | 0.01% |
Ausdal Financial Partners, Inc. | 23,000 | $19,000 | 0.01% |